 treatment acut myelocyt leukemia allogen bone marrow transplant prepar twenty-seven patient acut myelocyt leukemia aml mg/kg day cyclophosphamid mg/kg day allogen bone marrow transplant hla-ident antigen dispar sibl patient first complet remiss second complet remiss initi relaps patient primari refractori diseas second subsequ relaps preced hematolog disord leukemia-fre surviv lf actuari probabl relaps group multivari analys relaps lf advanc diseas phase french-american-british classif lf first remiss patient short time interv diagnosi transplant studi attract prepar regimen marrow transplant patient aml prognost factor relaps lf similar regimen total bodi irradi